Extract from the Register of European Patents

EP Citations: EP3464272

Cited inSearch
Type:Patent literature
Publication No.:WO2016203405  [XPI]
 (NOVARTIS AG et al.) [XP] 1,14 * claim 1 * * compound 24 on page 129, compound 50 on page 155, compounds 55 and 57 on page 156, compound 78 on page 162 *[I] 1-32
Cited inInternational search
Type:Patent literature
Publication No.:WO2015107495  [X]
 (NOVARTIS AG et al.) [X] 1-85 * see examples 2-4, 6-19, 26-28, 30-33, 40-41, 45-46, 52-53, 56-60, 63-64, 67-71, 73, 75, 77-81, 91-97, 99-102, claims 1-23 *
Type:Patent literature
Publication No.:WO2015107493  [X]
 (NOVARTIS AG et al.) [X] 1-85 * see examples 7-21, 27-28, claims 1-12 *
Type:Patent literature
Publication No.:WO2015107494  [X]
 (NOVARTIS AG et al.) [X] 1-85 * see examples 1-4, 6, 8, 10-13, 16-28, 32, 36-38, 42-44, 47-53, claims 1-12 *
Type:Patent literature
Publication No.:WO2016203406  [PX]
 (NOVARTIS AG et al.) [PX] 1-85 * see examples 1-133, claims 1-14 *
Cited inby applicant
Type:Patent literature
Publication No.:WO2015107495  
Type:Patent literature
Publication No.:WO2015107493  
Type:Patent literature
Publication No.:WO2015107494  
Type:Non-patent literature
Publication information:  "Design of Prodrugs", 1985, ELSEVIER
Type:Non-patent literature
Publication information:  "REMINGTON: THE SCIENCE AND PRACTICE OF PHARMACY", 1995, MACK PUBLISHING CO.